S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
Is the US Military Secretly Under Chinese Control? (Ad)
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
WTO predicts trade growth to slow next year amid crises
Is the US Military Secretly Under Chinese Control? (Ad)
Live Updates: Russia-Ukraine War
Stocks rise in extended rally, clawing back more ground
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
Is the US Military Secretly Under Chinese Control? (Ad)
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
WTO predicts trade growth to slow next year amid crises
Is the US Military Secretly Under Chinese Control? (Ad)
Live Updates: Russia-Ukraine War
Stocks rise in extended rally, clawing back more ground
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
Is the US Military Secretly Under Chinese Control? (Ad)
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
WTO predicts trade growth to slow next year amid crises
Is the US Military Secretly Under Chinese Control? (Ad)
Live Updates: Russia-Ukraine War
Stocks rise in extended rally, clawing back more ground
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Nevada Desert more Valuable than Wall Street or Silicon Valley? (Ad)
3 Safe Earnings Plays for a Risk-Off Market
Micron to bring microchip plant to upstate New York
Is the US Military Secretly Under Chinese Control? (Ad)
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
WTO predicts trade growth to slow next year amid crises
Is the US Military Secretly Under Chinese Control? (Ad)
Live Updates: Russia-Ukraine War
Stocks rise in extended rally, clawing back more ground
NYSE:A

Agilent Technologies - A Stock Forecast, Price & News

$131.41
+5.03 (+3.98%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$128.58
$131.56
50-Day Range
$121.55
$142.29
52-Week Range
$112.52
$165.68
Volume
1.63 million shs
Average Volume
1.83 million shs
Market Capitalization
$38.90 billion
P/E Ratio
29.93
Dividend Yield
0.66%
Price Target
$151.31

Agilent Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
15.1% Upside
$151.31 Price Target
Short Interest
Healthy
1.03% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.14
Upright™ Environmental Score
News Sentiment
0.53mentions of Agilent Technologies in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$595,069 Sold Last Quarter
Proj. Earnings Growth
7.89%
From $5.07 to $5.47 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.81 out of 5 stars

Computer And Technology Sector

116th out of 648 stocks

Analytical Instruments Industry

5th out of 29 stocks

A stock logo

About Agilent Technologies (NYSE:A) Stock

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Stock News Headlines

Agilent Technologies: Dividend Insights
Fortune Ranks Agilent Among Top Workplaces in Health Care
Agilent Receives Award for Sustainability Leadership
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Company Calendar

Ex-Dividend for 7/27 Dividend
7/01/2022
Dividend Payable
7/27/2022
Last Earnings
8/16/2022
Ex-Dividend for 10/26 Dividend
10/03/2022
Today
10/05/2022
Dividend Payable
10/26/2022
Fiscal Year End
10/31/2022
Next Earnings (Estimated)
11/28/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
17,000
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$151.31
High Stock Price Forecast
$178.00
Low Stock Price Forecast
$135.00
Forecasted Upside/Downside
+15.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$1.21 billion
Pretax Margin
22.48%

Debt

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$5.92 per share
Book Value
$17.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$38.90 billion
Optionable
Optionable
Beta
1.04

Social Links


Key Executives

  • Mr. Michael R. McMullenMr. Michael R. McMullen (Age 61)
    CEO, Pres & Director
    Comp: $4.51M
  • Mr. Robert W. McMahon (Age 53)
    Sr. VP & CFO
    Comp: $1.85M
  • Mr. Jacob ThaysenMr. Jacob Thaysen (Age 47)
    Sr. VP and Pres of Life Sciences & Applied Markets Group
    Comp: $1.54M
  • Mr. Samraat S. RahaMr. Samraat S. Raha (Age 49)
    Sr. VP and Pres of Diagnostics & Genomics Group
    Comp: $1.34M
  • Mr. Padraig McDonnellMr. Padraig McDonnell
    Sr. VP & Pres of Agilent Cross Lab Group
  • Mr. Rodney GonsalvesMr. Rodney Gonsalves (Age 56)
    Principal Accounting Officer, VP & Corp. Controller
  • Dr. Darlene J. S. Solomon Ph.D. (Age 63)
    CTO & Sr. VP
  • Mr. Michael TangMr. Michael Tang (Age 48)
    Sr. VP, Gen. Counsel & Sec.
  • Mr. Dominique P. GrauMr. Dominique P. Grau (Age 63)
    Sr. VP of HR & Global Communications
  • Ms. Allison Ballmer
    Sr. VP of Strategy & Corp. Devel.













A Stock - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2022?

13 Wall Street research analysts have issued 1-year target prices for Agilent Technologies' stock. Their A share price forecasts range from $135.00 to $178.00. On average, they expect the company's stock price to reach $151.31 in the next year. This suggests a possible upside of 15.1% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2022?

Agilent Technologies' stock was trading at $159.65 on January 1st, 2022. Since then, A stock has decreased by 17.7% and is now trading at $131.41.
View the best growth stocks for 2022 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 3,030,000 shares, an increase of 11.8% from the August 31st total of 2,710,000 shares. Based on an average daily volume of 1,470,000 shares, the days-to-cover ratio is presently 2.1 days. Currently, 1.0% of the shares of the company are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 28th 2022.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings results on Tuesday, August, 16th. The medical research company reported $1.34 EPS for the quarter, topping analysts' consensus estimates of $1.20 by $0.14. The medical research company had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.64 billion. Agilent Technologies had a net margin of 19.94% and a trailing twelve-month return on equity of 28.46%. Agilent Technologies's revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.10 earnings per share.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Wednesday, September 21st. Stockholders of record on Tuesday, October 4th will be given a dividend of $0.21 per share on Wednesday, October 26th. This represents a $0.84 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend is Monday, October 3rd.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.66%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 19.13%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its Board of Directors has initiated a stock buyback program on Tuesday, February 16th 2021, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 5% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its FY 2022 earnings guidance on Tuesday, September, 20th. The company provided earnings per share guidance of $5.06-$5.08 for the period, compared to the consensus earnings per share estimate of $4.76. The company issued revenue guidance of $6.75 billion-$6.78 billion, compared to the consensus revenue estimate of $6.51 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of retail and institutional investors. Top institutional investors include Fulton Bank N.A. (0.00%), Neville Rodie & Shaw Inc. (0.00%), Wedmont Private Capital (0.00%) and AdvisorNet Financial Inc (0.00%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $131.41.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $38.90 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $4.39 on an earnings per share basis.

How many employees does Agilent Technologies have?

The company employs 17,000 workers across the globe.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.